Option Care(OPCH)
Search documents
Option Care(OPCH) - 2023 Q4 - Annual Results
2024-02-21 16:00
• Net revenue of $1,124.4 million, up 9.5% compared to $1,027.2 million in the fourth quarter of 2022 • Gross profit of $247.1 million, or 22.0% of revenue, up 6.9% compared to $231.1 million, or 22.5% of revenue, in the fourth quarter of 2022 • Net income of $57.2 million, or $0.32 earnings per share, inclusive of the impact from non-operating income, compared to net income of $47.5 million, or $0.26 earnings per share in the fourth quarter of 2022 • Adjusted EBITDA of $111.6 million, up 18.4% compared to ...
Option Care (OPCH) is on the Move, Here's Why the Trend Could be Sustainable
Zacks Investment Research· 2024-02-20 14:50
While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn't easy.Often, the direction of a stock's price movement reverses quickly after taking a position in it, making investors incur a short-term capital loss. So, it's important to ensure that there are enough factors -- such as sound fundamentals, positive earnings estimate revisions, ...
Option Care Health Is Delivering The Future Of Healthcare At Home
Seeking Alpha· 2023-12-27 14:51
shironosov/iStock via Getty ImagesI’m drawn to Option Care Health (NASDAQ:OPCH) in 2024, the leading home infusion provider in the US. There are two pivotal healthcare mega-trends that OPCH is capitalizing on: i. the cost-effective shift to home-based healthcare delivery and ii. the rapid rise of specialty medicines. With a strong operational footprint across the nation and a conservative market estimate of $15bn, I believe OPCH is in a perfect spot to further expand its market through consolidation of ...
Option Care(OPCH) - 2023 Q3 - Earnings Call Transcript
2023-10-25 16:47
Option Care Health, Inc. (NASDAQ:OPCH) Q3 2023 Earnings Conference Call October 25, 2023 8:30 AM ET Company Participants Mike Shapiro - CFO John Rademacher - CEO Conference Call Participants David MacDonald - Truist Madeline Mollman - William Blair Lisa Gill - JPMorgan Joanna Gajuk - Bank of America Merrill Lynch Brian Tanquilut - Jefferies Jamie Perse - Goldman Sachs Pito Chickering - Deutsche Bank Michael Petusky - Barrington Research Operator Good day, and thank you for standing by. Welcome to the Option ...
Option Care(OPCH) - 2023 Q3 - Quarterly Report
2023-10-24 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 05-0489664 (State of incorpo ...
Option Care(OPCH) - 2023 Q2 - Earnings Call Transcript
2023-07-27 17:45
Option Care Health, Inc. (NASDAQ:OPCH) Q2 2023 Earnings Conference Call July 27, 2023 8:30 AM ET Company Participants Mike Shapiro – Chief Financial Officer John Rademacher – Chief Executive Officer Conference Call Participants Lisa Gill – JPMorgan Brian Tanquilut – Jefferies Matt Larew – William Blair David MacDonald – Truist Pito Chickering – Deutsche Bank Jamie Perse – Goldman Sachs Michael Petusky – Barrington Research Operator Good day and thank you for standing by. Welcome to the Option Care Health Se ...
Option Care(OPCH) - 2023 Q2 - Quarterly Report
2023-07-26 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 05-0489664 (State of incorporatio ...
Option Care(OPCH) - 2023 Q1 - Quarterly Report
2023-05-03 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 05-0489664 (State of incorporati ...
Option Care(OPCH) - 2022 Q4 - Earnings Call Transcript
2023-02-23 21:30
Option Care Health, Inc. (NASDAQ:OPCH) Q4 2022 Earnings Conference Call February 23, 2022 8:30 AM ET Company Participants Michael Shapiro - CFO & SVP John Rademacher - CEO, President & Director Conference Call Participants David MacDonald - Truist Securities Matthew Larew - William Blair Lisa Gill - JPMorgan Pito Chickering - Deutsche Bank Jamie Perse - Goldman Sachs Joanna Gajuk - Bank of America Operator Hello, and thank you for standing by. Welcome to Option Care Health Fourth Quarter 2022 Earnings Confe ...
Option Care(OPCH) - 2022 Q4 - Annual Report
2023-02-22 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-11993 OPTION CARE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 05-0489664 (State of incorporation) ( ...